Heart failure combo shows promise in small trial
NCT ID NCT06778330
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This study looked at whether adding sildenafil to the standard drug dapagliflozin helps heart failure patients who also have high blood pressure in their lungs. 100 people with mild heart failure took part. The goal was to see if the combination improved heart pumping strength and lowered lung blood pressure better than dapagliflozin alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS II are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fayoum University
Al Fayyum, Egypt
Conditions
Explore the condition pages connected to this study.